Have your own idea? Try our Stock Screener
Over the last 7 days, the Biotech industry has dropped 3.1%, driven by a pullback from Chongqing Zhifei Biological Products of 7.5%. Meanwhile, Suzhou Zelgen BiopharmaceuticalsLtd actually outperformed within the industry, gaining 5.1% in the last week. Overall the industry is down 24% in 12 months. As for the next few years, earnings are expected to grow by 39% per annum.
Has the Chinese Biotech Industry valuation changed over the past few years?
Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
---|---|---|---|---|---|---|
Mon, 09 Sep 2024 | CN¥758.1b | CN¥154.2b | CN¥14.5b | 30.5x | 52.2x | 4.9x |
Wed, 07 Aug 2024 | CN¥842.2b | CN¥161.2b | CN¥17.3b | 31.9x | 48.7x | 5.2x |
Fri, 05 Jul 2024 | CN¥797.9b | CN¥161.1b | CN¥17.3b | 28.7x | 46.1x | 5x |
Sun, 02 Jun 2024 | CN¥906.1b | CN¥161.1b | CN¥17.3b | 35.3x | 52.4x | 5.6x |
Tue, 30 Apr 2024 | CN¥945.8b | CN¥161.8b | CN¥18.2b | 35.1x | 51.8x | 5.8x |
Thu, 28 Mar 2024 | CN¥964.2b | CN¥164.4b | CN¥21.9b | 36.6x | 44.1x | 5.9x |
Sat, 24 Feb 2024 | CN¥992.7b | CN¥167.9b | CN¥21.4b | 34.6x | 46.3x | 5.9x |
Mon, 22 Jan 2024 | CN¥1.0t | CN¥167.9b | CN¥21.4b | 35.7x | 46.9x | 6x |
Wed, 20 Dec 2023 | CN¥1.1t | CN¥168.1b | CN¥21.5b | 40x | 50.8x | 6.5x |
Fri, 17 Nov 2023 | CN¥1.1t | CN¥168.1b | CN¥21.5b | 41.1x | 51.7x | 6.6x |
Sun, 15 Oct 2023 | CN¥1.1t | CN¥170.9b | CN¥25.2b | 44.3x | 43.1x | 6.4x |
Tue, 12 Sep 2023 | CN¥1.0t | CN¥170.7b | CN¥25.2b | 38.8x | 40.8x | 6x |
Thu, 10 Aug 2023 | CN¥1.1t | CN¥174.4b | CN¥28.4b | 39.6x | 37.6x | 6.1x |
Sat, 08 Jul 2023 | CN¥1.1t | CN¥177.4b | CN¥29.3b | 38.6x | 36.1x | 6x |
Mon, 05 Jun 2023 | CN¥1.1t | CN¥177.4b | CN¥29.3b | 42x | 37.5x | 6.2x |
Wed, 03 May 2023 | CN¥1.2t | CN¥180.7b | CN¥31.8b | 43.4x | 38.6x | 6.8x |
Fri, 31 Mar 2023 | CN¥1.2t | CN¥186.1b | CN¥36.8b | 39.3x | 33.5x | 6.6x |
Sun, 26 Feb 2023 | CN¥1.3t | CN¥179.5b | CN¥38.0b | 44.2x | 33.9x | 7.2x |
Tue, 24 Jan 2023 | CN¥1.3t | CN¥179.6b | CN¥38.2b | 42.6x | 34.9x | 7.4x |
Thu, 22 Dec 2022 | CN¥1.2t | CN¥175.6b | CN¥37.9b | 37.8x | 31.5x | 6.8x |
Sat, 19 Nov 2022 | CN¥1.3t | CN¥175.5b | CN¥37.9b | 41.6x | 34.7x | 7.5x |
Mon, 17 Oct 2022 | CN¥1.2t | CN¥174.5b | CN¥40.3b | 33.7x | 29.8x | 6.9x |
Wed, 14 Sep 2022 | CN¥1.2t | CN¥174.0b | CN¥40.1b | 34x | 30.6x | 7.1x |
Fri, 12 Aug 2022 | CN¥1.3t | CN¥171.9b | CN¥43.4b | 36.3x | 29.6x | 7.5x |
Sun, 10 Jul 2022 | CN¥1.3t | CN¥168.1b | CN¥42.4b | 38.7x | 31.7x | 8x |
Tue, 07 Jun 2022 | CN¥1.2t | CN¥168.1b | CN¥42.4b | 37.4x | 28.5x | 7.2x |
Thu, 05 May 2022 | CN¥1.2t | CN¥168.1b | CN¥42.5b | 34.3x | 28.4x | 7.2x |
Sat, 02 Apr 2022 | CN¥1.4t | CN¥153.1b | CN¥41.1b | 42.3x | 35.2x | 9.4x |
Mon, 28 Feb 2022 | CN¥1.4t | CN¥151.2b | CN¥40.3b | 44.9x | 35.5x | 9.5x |
Wed, 26 Jan 2022 | CN¥1.4t | CN¥143.8b | CN¥38.7b | 44.5x | 36x | 9.7x |
Fri, 24 Dec 2021 | CN¥1.5t | CN¥141.8b | CN¥38.5b | 48.5x | 39.9x | 10.8x |
Sun, 21 Nov 2021 | CN¥1.6t | CN¥145.1b | CN¥40.2b | 47.8x | 40.2x | 11.1x |
Tue, 19 Oct 2021 | CN¥1.6t | CN¥132.5b | CN¥34.9b | 46.1x | 44.5x | 11.7x |
Thu, 16 Sep 2021 | CN¥1.5t | CN¥130.3b | CN¥33.4b | 47.8x | 44.7x | 11.5x |
44.7x
Which industries have driven the changes within the Chinese Healthcare industry?
CN Market | -2.42% | |
Healthcare | -2.13% | |
Biotech | -3.15% | |
Biotech | -3.15% |
Which companies have driven the market over the last 7 days?
Company | Last Price | 7D | 1Y | Valuation | |
---|---|---|---|---|---|
688266 Suzhou Zelgen BiopharmaceuticalsLtd | CN¥58.08 | 5.1% +CN¥743.8m | 45.9% | PS37.8x | |
688062 Mabwell (Shanghai) Bioscience | CN¥23.21 | 3.7% +CN¥331.7m | -1.2% | PS48.5x | |
300294 China Resources Boya Bio-pharmaceutical GroupLtd | CN¥33.28 | 1.6% +CN¥257.2m | 12.9% | PE73.8x | |
688443 Chongqing Genrix Biopharmaceutical | CN¥27.76 | 1.7% +CN¥168.7m | -8.0% | PS9327x | |
688336 Sunshine Guojian Pharmaceutical (Shanghai) | CN¥17.10 | 1.1% +CN¥111.0m | -9.0% | PE32x |